Lenalidomide 5mg Capsule Franchise in Ahmedabad

Immunomodulatory Cancer Therapy Supplier in Mumbai

Lenabot 5 Capsule Distributor in Delhi

Lenalidomide Capsule Franchise Opportunity in Bangalore

Cancer Therapy Capsule Stockist in Hyderabad
Lenalidomide 5mg Export & Manufacturing in Chandigarh

Home/Products /lenalidomide-5mg-capsule

Lenabot 5 Capsule

Composition : Lenalidomide (5mg) Capsule

Dosage Form : Capsule

Packaging Type : in a Bottle

Packaging : 30 Capsules

Price : ₹0/-

Please Contact For Best Price

Lenabot 5 Capsule contains Lenalidomide 5mg, an immunomodulatory and anticancer medication indicated for the treatment of multiple myeloma, myelodysplastic syndromes, and certain hematologic malignancies. It helps in controlling abnormal cell proliferation and supporting immune system modulation.

Lenalidomide works by enhancing T-cell and natural killer (NK) cell activity, inhibiting angiogenesis, and inducing apoptosis in malignant cells, providing effective disease control and improving patient outcomes in oncology therapy.

For distributors and healthcare suppliers, Lenabot 5 Capsule is a high-demand oncology product, widely prescribed by hematologists, oncologists, and cancer care centers. The increasing need for effective multiple myeloma and hematologic malignancy treatments ensures steady market demand.

Adding Lenabot 5 Capsule to your oncology and immunomodulatory therapy segment creates strong opportunities in pharmacies, hospitals, cancer clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, patient acceptance, and broad therapeutic application make it a valuable addition for pharmaceutical distribution.

Read More

About the Product

Lenabot 5 Capsule contains Lenalidomide 5mg, an immunomodulatory and anticancer medication indicated for the treatment of multiple myeloma, myelodysplastic syndromes, and certain hematologic malignancies. It helps in controlling abnormal cell proliferation and supporting immune system modulation.

Lenalidomide works by enhancing T-cell and natural killer (NK) cell activity, inhibiting angiogenesis, and inducing apoptosis in malignant cells, providing effective disease control and improving patient outcomes in oncology therapy.

For distributors and healthcare suppliers, Lenabot 5 Capsule is a high-demand oncology product, widely prescribed by hematologists, oncologists, and cancer care centers. The increasing need for effective multiple myeloma and hematologic malignancy treatments ensures steady market demand.

Adding Lenabot 5 Capsule to your oncology and immunomodulatory therapy segment creates strong opportunities in pharmacies, hospitals, cancer clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, patient acceptance, and broad therapeutic application make it a valuable addition for pharmaceutical distribution.

Common side effects may include fatigue, nausea, diarrhea, constipation, or skin rash. Severe side effects, though rare, may include blood clots, low blood counts (anemia, neutropenia, thrombocytopenia), liver abnormalities, or serious allergic reactions. Regular monitoring of blood counts and overall health is important during treatment.

Lenabot 5 Capsule is indicated for the treatment of multiple myeloma in patients who have received prior therapies. It is also used in transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with deletion 5q cytogenetic abnormality.

Before starting Lenabot 5 Capsule, patients should inform their doctor of any history of blood clots, heart disease, liver or kidney problems, or if they are pregnant or planning pregnancy. Lenalidomide can cause serious birth defects, so effective contraception is mandatory during treatment. Do not stop or adjust the dose without medical guidance, and follow monitoring schedules strictly.

Store Lenabot 5 Capsule in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children and ensure the container is tightly sealed. Do not use the capsules beyond their expiration date.

Get in Touch